Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121773) titled 'Impact of Nalbuphine on Postoperative Analgesia in Elderly Patients Undergoing Total Hip Arthroplasty under the ERAS Concept' on April 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xuzhou Central Hospital
Condition:
Postoperative pain
Intervention:
Sufentanil group:Sufentanil postoperative analgesia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-02
Target Sample Size: Sufentanil group:50;Nalbuphine Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=316483
Disclaimer: Curated by...